人类多能干细胞衍生的视网膜质细胞:在分化和转化应用方面的进展
Jessica Yuen Wuen Ma1, Maciej Daniszewski2, Alice Pébay3,4,5
1Department of Anatomy and Physiology, The University of Melbourne, Melbourne, VIC, Australia. jessica.ma@unimelb.edu.au.
Molecular medicine (Cambridge, Mass.)
|December 8, 2025
概括
人类多能干细胞 (hPSCs) 可以在体外产生视网膜质细胞 (RGCs). 这为研究视觉神经病变,开发药物和探索视力丧失的细胞替代疗法提供了新的途径.
科学领域:
- 神经科学是一个神经科学.
- 干细胞生物学 干细胞生物学
- 眼科医生 眼科 眼科
背景情况:
- 视网膜质细胞 (RGCs) 对视力至关重要,它们的退化会在诸如青光眼等疾病中导致不可逆转的视力丧失.
- 对于RGC研究,动物模型在完全复制人类视网膜生物学方面是有限的.
- 人类多能干细胞 (hPSCs) 为RGC研究提供了一个可行的体外模型.
研究的目的:
- 审查RGC身份,成熟和亚型多样性的关键标记.
- 总结区分hPSC到RGC的进展情况.
- 要突出hPSC衍生RGCs在疾病建模,药物查和移植中的应用.
主要方法:
- 对RGC标记物和差异化协议的当前文献的审查.
- 对hPSC衍生的RGCs的功能性特征化方法的分析.
- 使用hPSC-RGCs评估疾病建模和治疗潜力.
主要成果:
- 确定确定RGC身份,成熟阶段和亚型多样性的关键标记.
- 成功的hPSC分化协议产生功能性的RGCs的总结.
- 在疾病建模和药物查中证明hPSC衍生的RGCs的实用性.
结论:
- hPSC是用于在体外生成RGC的宝贵工具,克服了传统模型的局限性.
- 由hPSC衍生的RGCs促进研究RGC退化和开发用于视力丧失的新疗法.
- 对hPSC-RGCs的进一步研究有望促进眼科和再生医学的发展.
相关概念视频
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Induced Pluripotent Stem Cells
27.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.2K


